Purchase Order SPE2DP24P0485
Award Date
4/26/24
Potential Completion Date
5/13/24
Potential Value
$2K
Federal Agency
Medical Supply Chain
Awardee
The Maclean Group LLC
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sacramento, CA 95825, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,010.06, was issued by the Medical Supply Chain division of the Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the purchase of 8510598440 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. The contract is a firm fixed-price purchase order with a completion date of May 13, 2024. The Maclean Group LLC is an...
This is a $11,055.33 firm-fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510615068 ! NALOXONE HYDROCHLORIDE, which is a medical product used to reverse opioid overdose. The award has a total small business set-aside designation and an ultimate completion date of May 21, 2024. The Maclean Group is an ISO...
The federal contract award, valued at $4,020.12, was issued by the Medical Supply Chain agency of the Department of Defense to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510598613 - Naloxone Hydrochloride, a medication used to reverse opioid overdose. This is a firm fixed-price purchase order contract with a completion date of May 13, 2024. The Maclean Group LLC is an ISO...
The U.S. government's Defense agency, specifically the Medical Supply Chain, has awarded a $4,020.12 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose, with a completion date of June 18, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale...
This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510696704 - Naloxone Hydrochloride, a critical drug used to treat opioid overdose. The award has a completion date of June 18, 2024 and is structured as a firm fixed price purchase order. The Maclean Group LLC is an ISO...
This contract was awarded by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The $18,090.54 firm fixed-price purchase order is for the delivery of 8510751637 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. The contract has a 100% small business set-aside and is scheduled for completion by July 29, 2024. The Maclean Group is an ISO 9001:2015 certified...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The $7,035.21 contract is for the supply of 8510639235 NALOXONE HYDROCHLORIDE, with a performance period ending on May 31, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that provides a range of products and services to...
This federal contract award, valued at $5,025.15, was issued by the Medical Supply Chain division of the Defense Department to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. This is a firm fixed price purchase order with a completion date of July 11, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical...
This federal contract award, valued at $1,005.03, was issued by the Defense agency Medical Supply Chain to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510987189 - Naloxone Hydrochloride, a medication used to reverse opioid overdose. The Maclean Group LLC has secured this firm-fixed price purchase order with an ultimate completion date of November 13, 2024. The company has established...
The U.S. Defense Logistics Agency awarded a firm-fixed-price purchase order contract worth $1,005.03 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride. The contract has an ultimate completion date of August 14, 2024 and was awarded on July 30, 2024. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor, has a diverse portfolio of federal...